Screening tool to address health disparities in NCORP clinical trial participants

Study ID: DCP-001

Use of a clinical screening tool to address cancer health disparities in the NCI Community Oncology Research Program (NCORP)

Researchers are collecting broader demographic and clinical data (e.g., socio-economic situation, co-morbidities, method of diagnosis) across the NCORP network to help identify and best characterize patients who are screened but not enrolled in, and for patients who participate in, certain NCI trials to understand how these variables may impact outcomes.

The goal is to implement a screening tool in NCORP to collect data that will help generate hypothesis and questions in the following areas of research: cancer screening, prevention, symptom science, cancer care disparities, comparative effectiveness and cancer care delivery.

Screened patients are defined as meeting the following minimum eligibility criteria per the protocol for which they are being screened:

  • Cancer diagnosis including stage and histology or pre-malignancy
  • Age range specified in the protocol for which the patient is being screened
  • Indication for the study intervention (e.g., symptom, toxicity)

Patients can be registered to DCP-001 once eligibility has been determined and they have been enrolled in the NCORP trial. They can be registered to DCP-001 up to four weeks after eligibility. Note that patients may still be registered to DCP-001 even if they have been deemed ineligible for the cancer control or treatment study.

Participants may be screened for more than one trial; however, DCP-001 informed consent document needs to be signed only once.

For the list of NCORP trials for which this disparities study applies, contact Elene Turzo at 484.476.2649.

Inclusion Snapshot

  • Must have received a cancer diagnosis
  • Must give consent to be included in this data-collection study

Contact Information

Lankenau Institute for Medical Research trial